BAFF serum levels in myasthenia gravis: effects of therapy (Q84074798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

BAFF serum levels in myasthenia gravis: effects of therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Flavia Scuderi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Emanuela Bartoccioni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Amelia Evoli

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Paolo E. Alboini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21559937

1 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21559937

1 December 2024

publication date

11 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 January 2020

http://link.springer.com/content/pdf/10.1007/s00415-011-6092-z.pdf

1 reference

10.1007/S00415-011-6092-Z

https://api.crossref.org/works/10.1007/S00415-011-6092-Z

http://link.springer.com/article/10.1007/s00415-011-6092-z/fulltext.html

1 December 2024

1 reference

10.1007/S00415-011-6092-Z

https://api.crossref.org/works/10.1007/S00415-011-6092-Z

http://link.springer.com/content/pdf/10.1007/s00415-011-6092-z

1 December 2024

1 reference

10.1007/S00415-011-6092-Z

Crossref

DOI

https://api.crossref.org/works/10.1007/S00415-011-6092-Z

1 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

2284-2285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559937%20AND%20SRC:MED&resulttype=core&format=json

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

31 January 2020

cites work

1 reference

12 December 2020

The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis.

1 reference

12 December 2020

The role of BAFF in B-cell maturation, T-cell activation and autoimmunity

1 reference

12 December 2020

High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

BAFF: a local and systemic target in autoimmune diseases

1 reference

12 December 2020

A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis

1 reference

12 December 2020

B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time

1 reference

12 December 2020

1 reference

12 December 2020

The kaleidoscope of glucorticoid effects on immune system

1 reference

12 December 2020

Serum BAFF expression in patients with myasthenia gravis.

1 reference

12 December 2020